Molecular Pathways: Old Drugs Define New Pathways: Non-Histone Acetylation at the Crossroads of the DNA Damage Response and Autophagy
Oronza A. Botrugno(European Institute of Oncology), Saverio Minucci(University of Milan), Marco Foiani(FIRC Institute of Molecular Oncology), Fabio Vanoli(IFOM), Thomas Robert(Centre National de la Recherche Scientifique)
Cited by 38
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
HDACs link the DNA damage response, processing of double-strand breaks and autophagy
|Nature|2011|410
The TopoVIB-Like protein family is required for meiotic DNA double-strand break formation
|Science|2016|316
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
|The EMBO Journal|2004|118
Mrc1 and Srs2 are major actors in the regulation of spontaneous crossover
|The EMBO Journal|2006|101